scispace - formally typeset
Search or ask a question
Institution

Georgetown University

EducationWashington D.C., District of Columbia, United States
About: Georgetown University is a education organization based out in Washington D.C., District of Columbia, United States. It is known for research contribution in the topics: Population & Cancer. The organization has 23377 authors who have published 43718 publications receiving 1748598 citations. The organization is also known as: GU & Georgetown.


Papers
More filters
Journal ArticleDOI
TL;DR: When combined with an optimized background regimen in both studies, a consistently favorable treatment effect of raltegravir over placebo was shown in clinically relevant subgroups of patients, including those with baseline characteristics that typically predict a poor response to antiretroviral therapy: a high HIV-1 RNA level, low CD4 cell count, and low genotypic or phenotypic sensitivity score.
Abstract: Background We evaluated the efficacy of raltegravir and the development of viral resistance in two identical trials involving patients who were infected with human immunodeficiency virus type 1 (HIV-1) with triple-class drug resistance and in whom antiretroviral therapy had failed. Methods We conducted subgroup analyses of the data from week 48 in both studies according to baseline prognostic factors. Genotyping of the integrase gene was performed in raltegravir recipients who had virologic failure. Results Virologic responses to raltegravir were consistently superior to responses to placebo, regardless of the baseline values of HIV-1 RNA level; CD4 cell count; genotypic or phenotypic sensitivity score; use or nonuse of darunavir, enfuvirtide, or both in optimized background therapy; or demographic characteristics. Among patients in the two studies combined who were using both enfuvirtide and darunavir for the first time, HIV-1 RNA levels of less than 50 copies per milliliter were achieved in 89% of raltegravir recipients and 68% of placebo recipients. HIV-1 RNA levels of less than 50 copies per milliliter were achieved in 69% and 80% of the raltegravir recipients and in 47% and 57% of the placebo recipients using either darunavir or enfuvirtide for the first time, respectively. At 48 weeks, 105 of the 462 raltegravir recipients (23%) had virologic failure. Genotyping was performed in 94 raltegravir recipients with virologic failure. Integrase mutations known to be associated with phenotypic resistance to raltegravir arose during treatment in 64 patients (68%). Forty-eight of these 64 patients (75%) had two or more resistance-associated mutations. Conclusions When combined with an optimized background regimen in both studies, a consistently favorable treatment effect of raltegravir over placebo was shown in clinically relevant subgroups of patients, including those with baseline characteristics that typically predict a poor response to antiretroviral therapy: a high HIV-1 RNA level, low CD4 cell count, and low genotypic or phenotypic sensitivity score. (ClinicalTrials.gov numbers, NCT00293267 and NCT00293254.)

524 citations

Journal ArticleDOI
TL;DR: This paper developed an intertemporal framework for measuring capital in which consumer utility maximization governs the expenditures that are current consumption versus those that are capital investment, and applied this principle to newly developed estimates of business spending on intangibles.
Abstract: Business outlays on intangible assets are usually expensed in economic and financial accounts Following Hulten (1979), this paper develops an intertemporal framework for measuring capital in which consumer utility maximization governs the expenditures that are current consumption versus those that are capital investment This framework suggests that any business outlay that is intended to increase future rather than current consumption should be treated as capital investment Applying this principle to newly developed estimates of business spending on intangibles, we find that, by about the mid-1990s, business investment in intangible capital was as large as business investment in traditional, tangible capital Relative to official measures, our framework portrays the US economy as having had higher gross private saving and, under plausible assumptions, fractionally higher average annual rates of change in real output and labor productivity from 1995 to 2002

523 citations

Journal ArticleDOI
TL;DR: In this paper, the authors suggest that researchers submitting manuscripts on entrepreneurial traits and characteristics should: ground their studies in the context of previous research, articulate a specific trait or characteristic, and present a specific set of characteristics.
Abstract: This article suggests that researchers submitting manuscripts on entrepreneurial traits and characteristics should: ground their studies in the context of previous research, articulate a specific t...

523 citations

Journal ArticleDOI
09 Dec 2016-Science
TL;DR: It is estimated that access to the Kenyan mobile money system M-PESA increased per capita consumption levels and lifted 194,000 households, or 2% of Kenyan households, out of poverty.
Abstract: Mobile money, a service that allows monetary value to be stored on a mobile phone and sent to other users via text messages, has been adopted by the vast majority of Kenyan households. We estimate that access to the Kenyan mobile money system M-PESA increased per capita consumption levels and lifted 194,000 households, or 2% of Kenyan households, out of poverty. The impacts, which are more pronounced for female-headed households, appear to be driven by changes in financial behavior-in particular, increased financial resilience and saving-and labor market outcomes, such as occupational choice, especially for women, who moved out of agriculture and into business. Mobile money has therefore increased the efficiency of the allocation of consumption over time while allowing a more efficient allocation of labor, resulting in a meaningful reduction of poverty in Kenya.

519 citations


Authors

Showing all 23641 results

NameH-indexPapersCitations
Cyrus Cooper2041869206782
David Cella1561258106402
Carl H. June15683598904
Ichiro Kawachi149121690282
Judy Garber14775679157
Bernard J. Gersh14697395875
Edward G. Lakatta14685888637
Eugene C. Butcher14644672849
Mark A. Rubin14569995640
Richard B. Devereux144962116403
Robert H. Purcell13966670366
Eric P. Winer13975171587
Richard L. Huganir13742561023
Rasmus Nielsen13555684898
Henry T. Lynch13392586270
Network Information
Related Institutions (5)
University of Pennsylvania
257.6K papers, 14.1M citations

95% related

Duke University
200.3K papers, 10.7M citations

95% related

Columbia University
224K papers, 12.8M citations

95% related

Yale University
220.6K papers, 12.8M citations

94% related

Harvard University
530.3K papers, 38.1M citations

94% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202396
2022412
20212,350
20202,311
20191,844
20181,767